Literature DB >> 24737499

Transoral robotic surgery for pharyngeal stenosis.

James K Byrd1, Rachel L Leonardis, Steven C Bonawitz, Joseph E Losee, Umamaheswar Duvvuri.   

Abstract

BACKGROUND: Pharyngeal stenosis is a complication of head and neck cancer and sleep apnea treatment that results in functional impairment. Due to the location of the stenosis and tendency to recur, surgical management is challenging. Robotic surgery may allow these areas to be treated with surgical technique that would be difficult using traditional approaches.
METHODS: A retrospective chart review was performed to identify patients who underwent transoral robotic surgery (TORS) for pharyngeal stenosis at a tertiary hospital system.
RESULTS: Five patients were identified, ages 8-75 years. Length of follow-up ranged from 1-12 months. There was one failure, a 74 year old male with a history of chemoradiation to the area who has required additional procedures.
CONCLUSION: TORS may offer improved surgical access to the pharynx in patients who require complex reconstruction that would otherwise be very difficult. Appropriate patient selection is necessary and long-term follow-up is warranted for the selected cases.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  local flaps; pharyngoplasty; robotics

Mesh:

Year:  2014        PMID: 24737499     DOI: 10.1002/rcs.1591

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  2 in total

1.  Reconstruction of TORS oropharyngectomy defects with the nasoseptal flap via transpalatal tunnel.

Authors:  Meghan T Turner; Mathew Geltzeiler; W Greer Albergotti; Umamaheswar Duvvuri; Robert L Ferris; Seungwon Kim; Eric W Wang
Journal:  J Robot Surg       Date:  2019-06-10

Review 2.  Alternative Applications of Trans-Oral Robotic Surgery (TORS): A Systematic Review.

Authors:  Giovanni Cammaroto; Luigi Marco Stringa; Henry Zhang; Pasquale Capaccio; Francesco Galletti; Bruno Galletti; Giuseppe Meccariello; Giannicola Iannella; Stefano Pelucchi; Ahmed Baghat; Claudio Vicini
Journal:  J Clin Med       Date:  2020-01-11       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.